Fusion Oncology fuses XGBoost drug-sensitivity models with DNABERT-2 genomic embeddings, then routes predictions through digital twin simulation, PK/PD pharmacokinetics, GNN scoring, and Bayesian uncertainty to produce confidence-scored companion diagnostic reports. - View it on GitHub